Celcuity Inc begins commercial transition with $1.33 per share loss in Q3
CELC Celcuity Inc
$67.05 -4.72%
View chart & analysis → - 1Celcuity Inc's Q3 loss was 9.5% better than consensus expectations.
- 2Celcuity Inc revenue decreased 44.6% compared to the previous year.
- 3Management raised the estimated second-line treatment market size to approximately $9 billion.
So what's the key point?
Celcuity Inc is starting its business with smaller losses than expected. The loss was 9.5% less than what experts predicted, and the company sees a larger market size ahead.
Source Earnings Whispers +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.